Pilot study of adding vincristine, topotecan, and cyclophosphamide to interval compressed chemotherapy in newly diagnosed patients with localized Ewing sarcoma: A report from the Children's Oncology Group

BACKGROUND: The combination of topotecan and cyclophosphamide is active in relapsed Ewing sarcoma family of tumors (ESFT). The feasibility of adding these agents combined with vincristine (VTC) to standard 5-drug chemotherapy with vincristine, doxorubicin, cyclophosphamide (VDC) and ifosfamide, etop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Mascarenhas, Leo, Felgenhauer, Judy. L., Bond, Mason C., Villaluna, Doojduen, Femino, J. Dominic, Laack, Nadia. N., Ranganathan, Sarangarajan, Meyer, James, Womer, Richard B., Gorlick, Richard, Krailo, Mark D., Marina, Neyssa
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4860347/
https://ncbi.nlm.nih.gov/pubmed/26579879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25837
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados